WHO ICTRP trial
Observational study to evaluate PD-L1 protein expression in Chinese patients…
ISRCTN10570964 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN10570964 |
|---|---|
| Public title | Observational study to evaluate PD-L1 protein expression in Chinese patients with advanced esophageal cancers and head and neck squamous cell carcinoma |
| Scientific title | A multi-center retrospective observational study to evaluate PD-L1 protein expression in Chinese patients with advanced esophageal cancers and head and neck squamous cell carcinoma |
| Primary sponsor | Merck Sharp and Dohme (China) |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Observational |
| Phase | Not Applicable |
| Countries | China |
| Conditions | Esophageal cancer and head and neck squamous cell carcinoma Cancer |
| Interventions | This is a multi-center retrospective non-interventional study designed to examine PD-L1 protein expression among 920 patients diagnosed with advanced EC and HNSCC at seven participating centers in China. Eligible patients should be 18 years… |
| Registration date | Apr 29, 2021 |
| Target size | 920 |
| Secondary IDs | Nil known;Nil known;8746 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: